Recent news on Xeloda

GlaxoSmithKline Reports Further Progress of Oncology Portfolio  -  25 May 2007
PR Newswire (press release),Xeloda(R) is a registered trademark of Roche Pharmaceuticals. Cautionary statement regarding forward-looking statements. Under the safe harbour provisions

Glaxo Plans 30 Presentations at Top Cancer Meeting  -  25 May 2007
Reuters.uk,...with advanced or metastatic HER-2 breast cancer who no longer respond to Herceptin. It is given in combination with Roche's oral chemotherapy drug Xeloda.

Many Health Plans that Cover Tykerb Are Using Prior Authorization  -  May 15, 2007
Atlantic Information Services, Inc.,The FDA on March 13 approved Tykerb in combination with Xeloda (capecitabine) for the treatment of HER2-(human epidermal growth factor receptor 2-) positive

Substantial Growth Forecasted for China's Colorectal Cancer Drug ...  -  May 16, 2007
PharmaLive.com (press release),...but that sales of Roche's Xeloda and biologics such as Merck's Erbitux and Roche's Avastin will grow most rapidly during the next five years.

Living With Cancer  -  May 4, 2007
NewsChannel 9 WSYR,She credits the drug Xeloda. “There are many women and men who have cancer, or who have gotten over cancer and they're cured who still live with it because

NCCN Updates Esophageal and Gastric Cancer Guidelines  -  May 22, 2007
PharmaLive.com (press release),In response to favorable Phase III trials (ML 17032 and REAL 2), the panel added oral fluoropyrimidine, Capecitabine (Xeloda(R), Roche) as an option for

NCCN Updates Esophageal and Gastric Cancer Guidelines  -  May 22, 2007
Genetic Engineering News (press release),In response to favorable Phase III trials (ML 17032 and REAL 2), the panel added oral fluoropyrimidine, Capecitabine (Xeloda(R), Roche) as an option for

New hope in breast cancer battle  -  May 6, 2007
NEWS.com.au,A study published in the New England Journal of Medicine showed that Tykerb in combination with chemotherapy drug Xeloda can delay the progress of cancer by

Roche updates on flu manufacturing; expands US unit  -  Apr 26, 2007
OutSourcing-Pharma.com,It has contributed to the development of manufacturing protocols for a number of Roche's leading brands, including cancer drug Xeloda (capecitabine),

Antisense—down, but not out  -  Apr 30, 2007
Nature.com (subscription),The company's GTI-2040, a second-generation phosphorothioate that is not highly chemically modified, is combined with the oral chemotherapy drug Xeloda

Roche updates on flu manufacturing; expands US unit  -  26 Apr 2007
In-PharmaTechnologist.com,It has contributed to the development of manufacturing protocols for a number of Roche's leading brands, including cancer drug Xeloda (capecitabine),

Roche Files Avastin, Xeloda for New Use in Europe  -  Apr 17, 2007
Reuters.uk,VX: Quote, Profile , Research) has filed its cancer drugs Avastin and Xeloda for label extensions for the treatment of colorectal cancer in Europe,

Roche files Avastin, Xeloda for new use in Europe  -  Apr 17, 2007
Therapeutics Daily (subscription) (press release),ZURICH (Reuters) - Swiss drugmaker Roche has filed its cancer drugs Avastin and Xeloda for label extensions for the treatment of colorectal cancer in Europe

Roche files license extensions for cancer drugs Avastin and Xeloda ...  -  Apr 16, 2007
Forbes,ZURICH (Thomson Financial) - Roche Holdings AG said it filed license extensions for its anti-angiogentic agent Avastin and oral chemotherapy Xeloda.

Roche Submits Application to the FDA for use of XELOX (Xeloda(R ...  -  Apr 5, 2007
Drug Newswire (press release),..."This filing marks a significant milestone for Xeloda, which continues to demonstrate its value as a cornerstone in combination therapies, as in this case

Xeloda Approved In Europe For The Treatment Of Advanced Stomach Cancer  -  Apr 2, 2007
Medical News Today (press release),The European Commission approved Xeloda in combination with platinum-based chemotherapy, for first-line use in patients with advanced stomach cancer.

Xeloda Approved in Europe for the Treatment of Advanced Stomach Cancer  -  Mar 30, 2007
PipelineReview.com (press release),BASEL, Switzerland | Mar 30, 2007 | The European Commission approved Xeloda in combination with platinum-based chemotherapy, for first-line use in patients

Xeloda Approved in Europe for the Treatment of Advanced Stomach Cancer  -  Mar 29, 2007
campus med,The clinical community welcomes this news as we now have a new option for our patients" Commenting on treatment with Xeloda, Annie, who was first diagnosed

Xeloda Approved in Europe for the Treatment of Advanced Stomach Cancer  -  Mar 29, 2007
Juraforum.de,The European Commission has approved Xeloda in combination withplatinum-based chemotherapy, for first-line use in patients withadvanced stomach cancer.

Roche Submits Application to the FDA for use of XELOX (Xeloda ...  -  Mar 31, 2007
WebWire (press release),Roche announced the submission of a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the use of Xeloda®

Roche's Xeloda Approved in Europe for Stomach Cancer  -  Mar 30, 2007
Reuters.uk,VX: Quote, Profile , Research) said on Friday its Xeloda drug had been approved in Europe for the treatment of advanced stomach cancer.

Roche's Xeloda combination treatment approved in EU for advanced ...  -  Mar 29, 2007
Forbes,BASEL (AFX) - Roche Holding AG said the European Commission has approved its Xeloda oral chemotherapy treatment in combination with platinum-based

Roche's Xeloda approved in EU for advanced stomach cancer  -  Mar 30, 2007
Pharma Times (subscription),Switzerland's Roche is celebrating another approval in Europe for its oral chemotherapy treatment Xeloda, this time in advanced stomach cancer.

Xeloda Receives Approval To Treat Stomach Cancer  -  Mar 30, 2007
E Canada Now,Boston (eCanadaNow) - News has come out stating that a new drug Xeloda has been approved to treat an advanced form of stomach cancer.

APS: Xeloda Approved in Europe for the Treatment of Advanced .....  -  Mar 29, 2007
ANP Pers Support,Taking Xeloda meant I had shorter hospital visits, more time with my. family, and more freedom to enjoy life as much as I could.

Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings ...  -  Apr 18, 2007
PharmaLive.com (press release),The expanding range of indications for our leading cancer drugs Avastin, Herceptin, Xeloda and MabThera establishes these innovative drugs as the gold

Roche applies for drug license extensions  -  Apr 17, 2007
newratings.comZRH) Tuesday announced that it had filed applications with the US Food and Drug Administration (FDA) for license extensions for the Avastin and Xeloda drugs

Roche Submits Application to the FDA for XELOX With or Without ...  -  Mar 28, 2007
EndoNurse,XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains XELODA (capecitabine) plus oxaliplatin.

Roche Q1 sales reach top end of forecasts, confirms sales growth ...  -  Apr 17, 2007
Forbes,Avastin, used in metastatic colorectal, breast, lung and renal cell cancer, achieved a sales increase of 41 pct, while sales of colon cancer drug Xeloda

The High Cost of New Cancer Therapies Has Made Them Targets for ...  -  Apr 20, 2007
Genetic Engineering News (press release),...or metastatic breast cancer in combination with Xeloda (capecitabine) in women who have received prior therapy, including Herceptin (trastuzumab).

Research and Markets: Ixabepilone is Predicted to Reach the Market ...  -  Apr 18, 2007
PharmaLive.com (press release),Ixabepilone is predicted to reach the market in late 2007 for the second-line treatment of patients with metastatic breast cancer in combination with Xeloda

Roche Q1 sales up 16 pct, raises outlook  -  Apr 17, 2007
Reuters...the world's largest maker of cancer drugs said on Wednesday, driven by new uses of its cancer treatments Avastin, Herceptin, Xeloda and MabThera.

Market Report -- In Play (ANX)  -  Apr 18, 2007
MSN MoneyTreatment with a regimen including CoFactor with 5-fluorouracil and capecitabine (Xeloda), an oral prodrug of 5-FU, demonstrated superior inhibition of

Roche First-Quarter Sales up 16%, Raises Outlook  -  Apr 17, 2007
CNBC,...the world's largest maker of cancer drugs said on Wednesday, driven by new uses of its top cancer treatments Avastin, Herceptin, Xeloda and MabThera.

Health Scan: Pre-army exams provide excellent database  -  Apr 7, 2007
Jerusalem Post,The FDA examined studies showing that when Tykerb (of GlaxoSmithKline) is given along with the drug Xeloda, another breast cancer drug from Roche

GSK gets FDA nod for cancer drug  -  Apr 4, 2007
Express Pharma,GlaxoSmithKline received an approval for Tykerb (lapatinib), in combination with Xeloda (capecitabine), for the treatment of patients with advanced or

OTN's Specialty Pharmacy, ivpcare, Selected to Dispense Newly ...  -  Mar 29, 2007
Drug Newswire (press release),Physicians can call in prescriptions for Tykerb and Xeloda to ivpcare at 800-424-9002 or fax them to 800-874-9179. Breast cancer patients can initiate an

GSK Seeks Approval In Japan For Breast Cancer Drug Tykerb  -  Apr 3, 2007
Therapeutics Daily (subscription) (press release),The drug maker is seeking government approval of Tykerb pills for monotherapy and combination treatment with Roche Holding AG's Xeloda tablet.

Cancer drug prices continue to soar  -  Mar 31, 2007
Bradenton Herald,The trouble with Tykerb is that it costs about $2900 per month and has to be given with another medicine called Xeloda that can run more than $1500 a month.

Targeted Breast Cancer Therapy  -  Mar 30, 2007
6abc.com,The newly approved drug is prescribed along with a chemotherapy called Xeloda and taken once a day by mouth. The targeted therapy attacks a protein made by

Roche's AVastin approved for metastatic breast cancer in EU  -  Mar 28, 2007
Forbes,Avastin in the first line treatment of metastatic breast cancer in combination with docetaxel and other commonly used chemotherapies including Xeloda.

sNDA Submitted for Xelox  -  Mar 30, 2007
Cancer Consultants (press release),...of Xelox (Xeloda® (capecitabine) plus Eloxatin® (oxaliplatin)) with or without Avastin® (bevacizumab) for the treatment of metastatic colorectal cancer.

ADVENTRX announces positive data from multidrug therapy with cofactor  -  Apr 22, 2007
News-Medical.net,Treatment with a regimen including CoFactor with 5-fluorouracil (5-FU) and capecitabine (Xeloda(R)), an oral prodrug of 5-FU, demonstrated superior

Pharma Sector: Few Newsmakers Of The Week - Pfizer, Merck, Glaxo ...  -  Apr 6, 2007
Trading Markets,Tykerb was approved by the FDA on March 13, 2007 to be used in combination with Roche's chemotherapy drug Xeloda for patients with advanced,

Health Scan: How to dispose of those old pills  -  Mar 31, 2007
Jerusalem Post,The FDA examines studies showing that when Tykerb (of GlaxoSmithKline) is given along with the drug Xeloda, another breast cancer drug from Roche

For Harvin, surviving is a journey, not an acquittal  -  Apr 19, 2007
Manning Times,Another round of radiation and an oral form of chemotherapy called Xeloda (which Harvin will take for the rest of her life), have left Harvin without any

Overall Approximately 3 Million Women in the US Are Living With ...  -  Apr 13, 2007
Genetic Engineering News (press release),Nolvadex and Arimidex), two chemotherapies (Xeloda and Taxotere) and one monoclonal antibody (Herceptin) as a treatment option for breast cancer.

Windfall for cos eyeing US oncology market  -  Apr 10, 2007
Economic Times,...will lose market exclusivity in 2009 in the US, while Roche Laboratories’ patent on colon and breast cancer drug Xeloda, will expire in 2010.

YM BioSciences Strengthens Program Management of Lead Drugs  -  Apr 5, 2007
Drug Newswire (press release),Global Project Management at Hoffman La-Roche Inc. with leadership responsibility through NDA filings and certain of the approvals for Xeloda(TM),

ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR ...  -  Apr 5, 2007
Drug Newswire (press release),...today that results from preclinical studies of ANX-510 (CoFactor(R)) in combination with intravenous 5-fluorouracil (5-FU) and capecitabine (Xeloda(R)),

Roche Submits Application to the FDA for use of XELOX (Xeloda(R ...  -  27 Mar 2007
PR Newswire (press release),..."This filing marks a significant milestone for Xeloda, which continues to demonstrate its value as a cornerstone in combination therapies, as in this case

FDA Approves TYKERB® in Combination With Xeloda® for the Treatment ...  -  Mar 20, 2007
Pharmaceutical Processing,GlaxoSmithKline recently announced that the FDA has approved TYKERB® (lapatinib), in combination with Xeloda® (capecitabine), for the treatment of patients

FDA Approves Tykerb® (lapatinib) In Combination With Xeloda ...  -  Mar 19, 2007
Medical News Today (press release),Herceptin® is a registered trademark of Genentech, Inc. in the USand Roche Pharmaceuticals in Europe. Xeloda® is a registered trademark of Roche

FDA Approves Tykerb And Xeloda To Treat Advanced Breast Cancer  -  Mar 13, 2007
All Headline NewsThe GlaxoSmithKline PLC drug, Tykerb (lapatinib) in combination with Xeloda (capecitabine) is to be taken once daily in pill form by women who have received

New Hope in the Fight Against Breast Cancer  -  Mar 24, 2007
Associated Content,The new pill is to be used in conjunction with Xeloda (capecitabine), a chemotherapy pill. While it is not known if the new pill will help women live longer

FDA Approves TYKERB(R) (lapatinib) In Combination With Xeloda(R ...  -  Mar 14, 2007
Medical News Today (press release),Herceptin(R) is a registered trademark of Genentech, Inc. in the US and Roche Pharmaceuticals in Europe. Xeloda(R) is a registered trademark of Roche

FDA Approves TYKERB(R) (lapatinib) in Combination With Xeloda(R ...  -  Mar 13, 2007
PR Newswire (press release),Xeloda(R) is a registered trademark of Roche Pharmaceuticals. Inquiries: US Media inquiries: Sarah Alspach +1 919 483 2839 Mary Anne Rhyne +1 919 483 2839

FDA approves Tykerb® (lapatinib) in combination with Xeloda ...  -  Mar 14, 2007
WebWire (press release),...in combination with Xeloda® (capecitabine), for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and

FDA approves Tykerb and Xeloda for the treatment of advanced or ...  -  Mar 13, 2007
HULIQ,FDA approves Tykerb (lapatinib) in combination with Xeloda (capecitabine) for the treatment of advanced or metastatic breast cancer in women who have

FDA Approves TYKERB(R) (lapatinib) in Combination With Xeloda(R ...  -  Mar 13, 2007
PR Newswire (press release),Xeloda(R) is a registered trademark of Roche Pharmaceuticals. To access the latest GSK Oncology media materials, visit https://www.gsk/media.com or

FDA Approves Glaxo's (GSK) TYKERB in Combination With Xeloda for ...  -  Mar 13, 2007
StreetInsider.com (subscription),...in combination with Xeloda, for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received

GlaxoSmithKline Says FDA Approves TYKERB In Combination With ...  -  Mar 13, 2007
Trading Markets,L) announced that the United States Food and Drug Administration (FDA | charts | news | PowerRating) approved TYKERB (lapatinib), in combination with Xeloda

Oral Cancer Drug Xeloda Receives Positive Opinion From The ...  -  Feb 26, 2007
Medical News Today (press release),Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a positive

Biotech in Review: Genentech Extends Uses for Avastin and Xeloda  -  Feb 25, 2007
Seeking Alpha,Xeloda was previously approved for colon cancer, and Avastin was on the market for colorectal cancer. Xeloda was proved to be as effective as 5-flurouracil,

Diplomat Specialty Pharmacy Provides Tykerb(R) - National Oncology ...  -  Mar 22, 2007
Drug Newswire (press release),The announcement comes on the heels of the FDA's approval of Tykerb in combination with Xeloda(R) for the treatment of advanced metastatic breast cancer in

OTN's Specialty Pharmacy, ivpcare, Selected to Dispense Newly ...  -  Mar 22, 2007
SYS-CON Media,Physicians can call in prescriptions for Tykerb and Xeloda to ivpcare at 800-424-9002 or fax them to 800-874-9179. Breast cancer patients can initiate an

FDA approves new drug for advanced breast cancer  -  Mar 19, 2007
Post-Bulletin,The Food and Drug Administration said it approved Tykerb for use in conjunction with the chemotherapy drug Xeloda. Glaxo said Tykerb would be available in

FDA Approves New Breast Cancer Drug  -  Mar 13, 2007
WebMDThe FDA approved Tykerb for use in combination with another cancer drug, Xeloda, to treat certain patients with advanced breast cancer or breast cancer that

Tykerb® Approved for Advanced Breast Cancer  -  Mar 15, 2007
Cancer Consultants (press release),The indication for Tykerb includes its use in combination with the chemotherapy agent Xeloda® (capecitabine) for the treatment of advanced or metastatic

Anti-tumor drugs lifelong treatment  -  Mar 23, 2007
Denver Post,If the cancer has spread more widely, Edwards' physician is likely to be more aggressive, using drugs such as Xeloda - an oral drug that blocks an enzyme

OTN's Specialty Pharmacy, ivpcare, Selected to Dispense Newly ...  -  Mar 22, 2007
Earthtimes.org...approved Tykerb on March 13, 2007, for the treatment of advanced or metastatic breast cancer in combination with Xeloda(R) (capecitabine).

FDA approves new GSK drug for advanced breast cancer  -  Mar 13, 2007
FayObserver.com,The Food and Drug Administration said it approved Tykerb for use in conjunction with the chemotherapy drug Xeloda. Glaxo, which has dual US headquarters in

FDA Approves GSK Late-Stage Breast Cancer Drug Tykerb  -  Mar 14, 2007
Compliance Home,...(March 13, 2007)--FDA has approved GlaxoSmithKline's breast cancer drug Tykerb in combination with Roche's chemotherapy drug Xeloda as a treatment for women

FDA Approves GSK Late-Stage Breast Cancer Drug Tykerb  -  Mar 14, 2007
Kaiser network.org,FDA on Tuesday approved GlaxoSmithKline's breast cancer drug Tykerb in combination with Roche's chemotherapy drug Xeloda as a treatment for women with

New Drug For Advanced Breast Cancer Gets FDA Approval  -  Mar 14, 2007
Medical News Today,Tykerb (GlaxoSmithKline's brand name for lapatinib) is a new targeted anti-cancer drug taken in pill form with Xeloda (Roche's brand name for capecitabine,

New Breast Cancer Drug Given FDA Approval  -  Mar 13, 2007
Associated Content,The Food and Drug Administration (FDA) said it approved Tykerb for use along with the chemotherapy drug Xeloda. The drug, which will be available by the end

GlaxoSmithKline's Breast Cancer Drug Tykerb Gets FDA Approval  -  Mar 13, 2007
Trading Markets,Studies with Tykerb were halted in April last year after a preliminary analysis of 321 patients comparing combination treatment of Xeloda and Tykerb with

Tykerb: New drug for advanced HER-2 breast cancer  -  Mar 14, 2007
MayoClinic.comTykerb — which has the generic name lapatinib — is approved for use in combination with the chemotherapy drug capecitabine (Xeloda).

FDA Grants Approval for New Breast Cancer Drug from GSK  -  Mar 13, 2007
Local Tech Wire,The results of a study published last year showed that Tykerb in combination with Xeloda delayed tumor growth for an average of 8 1/2 months, or about twice

FDA Approves Breast Cancer Drug Tykerb  -  Mar 18, 2007
TopCancerNews.com,Tykerb has been approved by the FDA for use in conjunction with the chemotherapy drug Xeloda. Tykerb is a cancer medication that more precisely targets

Glaxo Cancer Pill May Win Approval After Almost Being Abandoned  -  Mar 11, 2007
BloombergTykerb, used with Roche Holding AG's Xeloda, attacks breast cancer tumors in women who carry a gene that makes the disease more aggressive, London-based

GlaxoSmithKline: Tykerb set to boost oncology portfolio  -  Mar 15, 2007
Pharmaceutical Business Review...'Content The FDA has granted regulatory approval to GlaxoSmithKline's Tykerb (lapatinib) in combination with Roche's Xeloda (capecitabine) for the treatment

FDA Approves Glaxo Cancer Drug  -  Mar 13, 2007
New York Times,The FDA approved the pill to be taken once daily in combination with Xeloda, from Roche, for treatment of advanced breast cancer in women who carry the

Tykerb® Approved for Advanced Breast Cancer  -  Mar 14, 2007
Cancer Consultants (press release),The indication includes the use of Tykerb plus Xeloda® (capecitabine) among women with advanced or metastatic breast cancer that over expresses the human

FDA gives green signal for Glaxo's new breast cancer drug  -  Mar 14, 2007
The Money Times,The health agency cleared the drug for patients with advanced breast cancer in combination with Roche Holding's oral chemotherapy drug, Xeloda,

Glaxo Gets US Approval for Tykerb, a Breast-Cancer Medication  -  Mar 14, 2007
Seeking Alpha,The FDA has approved the drug's use in combination with Roche's Xeloda for treatment of advanced breast cancer in women who carry the HER-2 gene and don't

Glaxo Wins US Approval of Breast-Cancer Drug Tykerb (Update2)  -  Mar 13, 2007
BloombergThe regulator approved the once-daily pill in combination with Roche Holding AG's Xeloda for treatment of advanced breast cancer in women who carry the

US approves new drug for aggressive breast cancer  -  Mar 13, 2007
CBC Saskatchewan,Time to tumour worsening was significantly better in those receiving Tykerb and Xeloda compared to Xeloda alone, the FDA said.

(AP) FDA Approves Advanced Breast Cancer Drug  -  Mar 13, 2007
WKRN,The results of a study published last year showed that Tykerb in combination with Xeloda delayed tumor growth for an average of 8.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional